ClearPoint Neuro Inc has a consensus price target of $22.5 based on the ratings of 4 analysts. The high is $30 issued by Lake Street on January 21, 2025. The low is $15 issued by B. Riley Securities on April 5, 2022. The 3 most-recent analyst ratings were released by Stifel, B. Riley Securities, and Lake Street on April 1, 2025, January 28, 2025, and January 21, 2025, respectively. With an average price target of $25 between Stifel, B. Riley Securities, and Lake Street, there's an implied 106.02% upside for ClearPoint Neuro Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/01/2025 | Buy Now | 106.02% | Stifel | Mathew Blackman60% | $19 → $25 | Maintains | Buy | Get Alert |
01/28/2025 | Buy Now | 64.81% | B. Riley Securities | Neil Chatterji35% | $15 → $20 | Maintains | Buy | Get Alert |
01/21/2025 | Buy Now | 147.22% | Lake Street | Frank Takkinen40% | $17 → $30 | Maintains | Buy | Get Alert |
08/27/2024 | Buy Now | 23.61% | Lake Street | Frank Takkinen40% | $11 → $15 | Maintains | Buy | Get Alert |
03/13/2024 | Buy Now | -25.83% | Stifel | Mathew Blackman60% | $8 → $9 | Reiterates | Buy → Buy | Get Alert |
10/24/2023 | Buy Now | -34.07% | Stifel | Mathew Blackman60% | → $8 | Initiates | → Buy | Get Alert |
08/09/2023 | Buy Now | 23.61% | Lake Street | Frank Takkinen40% | $22 → $15 | Maintains | Buy | Get Alert |
02/16/2023 | Buy Now | 15.37% | B. Riley Securities | Neil Chatterji35% | → $14 | Reinstates | → Buy | Get Alert |
04/05/2022 | Buy Now | 23.61% | B. Riley Securities | Marc Wiesenberger75% | → $15 | Reinstates | → Buy | Get Alert |
The latest price target for ClearPoint Neuro (NASDAQ:CLPT) was reported by Stifel on April 1, 2025. The analyst firm set a price target for $25.00 expecting CLPT to rise to within 12 months (a possible 106.02% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for ClearPoint Neuro (NASDAQ:CLPT) was provided by Stifel, and ClearPoint Neuro maintained their buy rating.
There is no last upgrade for ClearPoint Neuro
There is no last downgrade for ClearPoint Neuro.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ClearPoint Neuro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ClearPoint Neuro was filed on April 1, 2025 so you should expect the next rating to be made available sometime around April 1, 2026.
While ratings are subjective and will change, the latest ClearPoint Neuro (CLPT) rating was a maintained with a price target of $19.00 to $25.00. The current price ClearPoint Neuro (CLPT) is trading at is $12.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.